| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a280890863f53c408b82d723b6746baa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ef5a5d2401143bf66360924e11b6ce1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6d6ba515c455ff621e2ed2ae99a026d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42f352cc5bd193c17ffff15bf60e16f7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4747
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
| filingDate |
2011-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a87147a66ea58fe5f6be8dc57c13dd5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9dc3ef948332a764bb072bd708372ee7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61a4ecfebb983ca3e77e8ce11d4f694a |
| publicationDate |
2012-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012042038-A2 |
| titleOfInvention |
Chimeric peptides including a penetrating peptide and a binding domain of pp2a catalytic subunit to caspase-9 |
| abstract |
The invention related to chimeric peptides including a penetrating peptide and a binding domain of PP2A catalytic subunit to caspase-9 which have pro-apoptotic activity. These chimeric peptides may be used for the treatment of hyperproliferative disorders. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015063747-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2881472-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-3000746-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017503484-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015086583-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016156538-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10508310-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9364514-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2868326-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014106720-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016156536-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017079725-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013098339-A1 |
| priorityDate |
2010-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |